Health CanadaType II
Riva-Oxazepam: Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may ...
Published: September 22, 2022Recall ID: 64575Category: generalCountry: Canada
Reason for Recall / Hazard
Labelling
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
Riva-Oxazepam
Additional Source Details
| Field | Value |
|---|---|
| N I D | 64575 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/riva-oxazepam-incorrect-label-riva-oxazepam-30mg-500-tablets-din00568414-may-be |
| Issue | Labelling |
| Title | Riva-Oxazepam: Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406 |
| Product | Riva-Oxazepam |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-09-22 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |